STAQ Pharma of Ohio, LLC
FDA 503B outsourcing facility
Columbus, Ohio
Key Takeaways
- FDA-registered 503B outsourcing facility since 2023
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: May 16, 2025
- FDA action: Untitled Letter Issued 12/5/2025 and FMD-145 Letter Issued 12/5/2025
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- January 26, 2023
- Most recent registration
- December 18, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- May 16, 2025
The FDA last inspected STAQ Pharma of Ohio, LLC on May 16, 2025. Investigators issued a Form FDA 483 listing inspectional observations at that visit. FDA action on record: Untitled Letter Issued 12/5/2025 and FMD-145 Letter Issued 12/5/2025.
What this facility compounds
STAQ Pharma of Ohio, LLC reports compounding 6 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).
- Dexmedetomidine Hydrochloride
- Lidocaine Hydrochloride
- Methotrexate
- Phenylephrine Hydrochloride
- Sodium Chloride
- Succinylcholine Chloride
Location
25 Phillipi Rd, Columbus, OH 43228
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Mark Spiecker, 1-303-921-5789. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of STAQ Pharma of Ohio, LLC with the State of Ohio Board of Pharmacy.
503B facilities in Ohio
Ohio has 3 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Ohio.
Frequently asked questions
Is STAQ Pharma of Ohio, LLC registered with the FDA?
Yes. STAQ Pharma of Ohio, LLC is a registered 503B outsourcing facility, first registered with the FDA on January 26, 2023 and most recently registered on December 18, 2025.
Has STAQ Pharma of Ohio, LLC been inspected by the FDA?
The FDA last inspected STAQ Pharma of Ohio, LLC on May 16, 2025. A Form FDA 483 was issued. FDA action on record: Untitled Letter Issued 12/5/2025 and FMD-145 Letter Issued 12/5/2025.
Has STAQ Pharma of Ohio, LLC had any FDA drug recalls?
No FDA drug recalls are matched to STAQ Pharma of Ohio, LLC in the openFDA enforcement database.
What does STAQ Pharma of Ohio, LLC compound?
STAQ Pharma of Ohio, LLC reports compounding 6 active ingredients to the FDA.
Where is STAQ Pharma of Ohio, LLC located?
STAQ Pharma of Ohio, LLC is located in Columbus, Ohio (25 Phillipi Rd).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by STAQ Pharma of Ohio, LLC. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.